Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ampersand Biomedicines
Ampersand Biomedicines

Ampersand Biomedicines

Series D

Ampersand Biomedicines: Innovating disease-targeted programming therapeutics via our AND™ Platform.

HQ
Boston, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees

Founded by Flagship Pioneering, Ampersand Biomedicines is dedicated to revolutionizing drug development through its Address, Navigate, Design (AND)™ Platform. The company's core mission is to create novel programming therapeutics that act precisely at the site of disease, enhancing efficacy while maintaining safety and tolerability. Ampersand focuses on developing these targeted therapies to overcome the traditional challenges of affecting healthy tissues or cells, aiming to significantly improve patient outcomes.

Notable affiliated individuals include the team at Flagship Pioneering, a well-regarded venture capital firm known for incubating transformative biotech companies. Ampersand Biomedicines has achieved significant milestones in its early stages, particularly in advancing its AND™ Platform. The company's innovative approach has the potential to make a substantial impact on the biomedicine field by offering more precise and safer treatment options for various diseases.

Ampersand Biomedicines - Similar Companies

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Alltrna logo

Alltrna

alltrna.com

Generate Biomedicines logo

Generate Biomedicines

Montai Health logo

Montai Health

montai.com

ABio-X logo

ABio-X

abio-x.com

Amber Bio logo

Amber Bio

amber.bio

Amplifica logo

Amplifica

amplificabio.com

Surf Bio logo

Surf Bio

surf.bio

Rectify Pharmaceuticals logo

Rectify Pharmaceuticals

rectifypharma.com

Endpoint Health logo

Endpoint Health

endpointhealth.com

Ampel Biosolutions logo

Ampel Biosolutions

Cambrian BioPharma logo

Cambrian BioPharma

cambrianbio.com

EpiBiologics logo

EpiBiologics

epibiologics.com

Amplicore logo

Amplicore

AltPep logo

AltPep

altpep.com

Ampersand Biomedicines - Quick Facts

Who are Ampersand Biomedicines' competitors?

Companies similar to Ampersand Biomedicines include ProFound Therapeutics, Alltrna, Generate Biomedicines and Montai Health.

When was Ampersand Biomedicines founded?

Ampersand Biomedicines was founded in 2020.

Where is Ampersand Biomedicines' headquarters located?

Ampersand Biomedicines' headquarters is located in Boston, MA, US.

When was Ampersand Biomedicines' last funding round?

Ampersand Biomedicines' most recent funding round was for $50M (USD) in March 2023.

How much has Ampersand Biomedicines raised to-date?

As of Mar 7, 2023, Ampersand Biomedicines has raised a total of $50M (USD).

How many employees does Ampersand Biomedicines have?

Ampersand Biomedicines has 30 employees as of Feb 4, 2024.

Ampersand Biomedicines - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified